Skip to content
healthcare.dev
Get a free key

USTEKINUMAB-TTWE

NDC 82009-161, ustekinumab-ttwe, injection, solution, from Quallent Pharmaceuticals Health LLC.

Product NDC
82009-161
Status
Listed
Labeler
Quallent Pharmaceuticals Health LLC
Dosage form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761373
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/82009-161 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • USTEKINUMAB45 mg/.5mL

Pharmacologic classes

Interleukin-12 Antagonist [EPC]; Interleukin-12 Antagonists [MoA]; Interleukin-23 Antagonist [EPC]; Interleukin-23 Antagonists [MoA]

Package NDCNDC-11Package
82009-161-9482009016194.5 mL in 1 VIAL (82009-161-94)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/2b34392a-ecf6-41bd-8706-d4e9f0b25da8

Use it

Look up 82009-161 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/82009-161 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 82009-161. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.